DGCR5 was first reported to be downregulated in Huntington’s disease [16], and other studies have demonstrated that DGCR5 plays a role in the progression of many cancers including lung cancer [17] and hepatocellular carcinoma [14]. This evidence concerns the gene DGCR5 and hepatocellular carcinoma.